influenza
viru
one
major
caus
contagi
respiratori
ill
although
influenza
viru
caus
recurr
epidem
also
occasion
sever
pandem
exampl
includ
global
outbreak
highli
pathogen
avian
influenza
viru
outbreak
influenza
viru
spread
influenza
viru
seriou
outcom
influenza
infect
complic
observ
certain
group
patient
especi
elderli
young
children
therefor
rapid
accur
diagnosi
import
help
plan
treatment
regimen
ie
optim
antivir
therapi
reduct
antibiot
use
prevent
transmiss
clinic
diagnosi
influenza
basi
clinic
sign
symptom
alon
limit
due
similar
ill
caus
respiratori
pathogen
help
aid
clinic
judgment
diagnosi
influenza
number
differ
techniqu
develop
techniqu
includ
viral
cultur
molecular
assay
rapid
antigen
diagnost
test
although
viral
cultur
molecular
assay
allow
inform
regard
identif
outbreak
strain
subtyp
made
timeconsum
techniqu
often
requir
sophist
expens
equip
unlik
approach
result
interpret
rapid
antigen
diagnost
test
made
within
min
specimen
collect
requir
laboratori
expertis
rapid
diagnost
test
provid
simpl
lowcost
analysi
make
avail
screen
tool
lowresourc
set
ie
nurs
home
outpati
set
remot
healthcar
set
major
test
base
upon
detect
target
analyt
given
platform
platform
exampl
includ
paperbas
devic
membranebas
assay
labonachip
devic
platform
provid
advantag
simplic
portabl
inexpens
rapid
analysi
analyt
applic
system
offer
rapid
test
analysi
capillarydriven
platform
call
later
flow
immunochromatograph
assay
within
system
target
analyt
captur
two
specif
recognit
molecul
antibodi
form
sandwich
complex
case
test
employ
two
specif
antibodi
one
conjug
report
molecul
whilst
immobil
solid
support
complex
flow
along
test
devic
separ
sampl
matrix
via
capillari
forc
porou
membran
captur
target
detect
accomplish
via
optic
signal
readout
label
sandwich
complex
provid
direct
colorimetr
visual
report
molecul
gold
nanoparticl
commonli
use
previou
system
use
differ
size
gold
nanoparticl
form
duallay
gold
nanoparticl
report
differ
system
use
either
report
molecul
signal
enhanc
techniqu
fluoresc
dye
near
infrar
dye
magnet
nanoparticl
silver
enhanc
surfaceenhanc
raman
scatter
base
enzym
amplif
doubleantigen
target
strategi
also
report
howev
system
often
requir
either
addit
instrument
step
result
interpret
altern
use
carbon
nanomateri
report
molecul
great
potenti
use
variou
applic
due
uniqu
properti
exampl
good
chemic
stabil
biocompat
high
contrast
use
carbon
nanoparticl
report
offer
good
prospect
design
detect
platform
biomed
diagnost
applic
herein
develop
carbon
nanotag
base
later
flow
immunoassay
influenza
viru
detect
describ
carbon
nanoparticl
particular
carbon
nanostr
use
report
molecul
later
flow
immunoassay
system
base
upon
previou
feasibl
studi
use
carbon
nanoparticl
rapid
antigen
detect
test
system
optim
evalu
investig
potenti
clinic
applic
system
perform
develop
system
describ
firstli
follow
system
design
optim
step
subsequ
evalu
perform
system
influenza
viru
detect
complex
biolog
matric
system
appli
detect
viru
influenza
ainfect
sampl
allanto
fluid
cell
lysat
directli
bovin
serum
albumin
bsa
polyvinyl
pyrrolidon
obtain
sigma
aldrich
mo
usa
http
wwwsigmaaldrichcom
nonfat
dri
milk
tween
purchas
biorad
ca
usa
http
wwwbioradcom
later
flow
immunochromatograph
test
strip
compon
includ
nitrocellulos
membran
absorpt
pad
obtain
ge
healthcar
buckinghamshir
uk
http
wwwgelifesciencescom
glass
fiber
conjug
pad
sampl
applic
pad
suppli
merck
millipor
usa
http
wwwmerckmilliporecom
carbon
nanoparticl
form
nanostr
purchas
maiia
diagnost
uppsala
sweden
http
maiiadiagnosticscom
chemic
analyt
grade
purchas
sigma
aldrich
ultrapur
water
obtain
use
milliq
system
merck
millipor
use
throughout
experi
transmiss
electron
microscopi
tem
scan
electron
microscop
sem
imag
taken
jeol
japan
fieldemiss
scan
electron
microscop
fesem
hitachi
japan
zetas
malvern
instrument
uk
use
measur
dynam
light
scatter
dl
nanoparticl
biodot
dispens
ca
usa
use
gener
control
line
nitrocellulos
membran
mous
monoclon
antiinfluenza
nucleoprotein
antibodi
secondari
goat
antimous
igg
antibodi
suppli
innova
biotechnolog
bangkok
thailand
http
wwwinnovabiotechnologycom
kpl
md
usa
http
wwwseracarecom
respect
allanto
fluid
inocul
influenza
viru
prepar
describ
previous
madindarbi
canin
kidney
mdck
cell
cultur
infect
influenza
viru
use
two
clinic
human
isol
season
influenza
season
influenza
produc
describ
previous
viral
manipul
perform
appropri
biosafeti
level
plu
condit
compon
prepar
carbon
nanotagantibodi
immunoprob
fig
b
describ
briefli
follow
procedur
stock
suspens
carbon
nanoparticl
homogen
sonic
bath
dilut
differ
fold
mm
borat
buffer
ph
monoclon
antiinfluenza
nucleoprotein
antibodi
dilut
concentr
mm
borat
buffer
ph
dilut
antibodi
ad
dilut
suspens
carbon
nanoparticl
molar
ratio
antibodi
carbon
nanoparticl
mix
min
block
solut
ad
mixtur
continu
stir
min
pellet
collect
centrifug
g
min
resuspend
pellet
resuspend
buffer
bsa
mm
borat
buffer
ph
final
immunoprob
store
use
character
particl
includ
chang
size
surfac
charg
shown
electron
support
materi
esm
fig
carbon
nanotag
base
later
flow
assay
test
system
consist
compon
includ
sampl
applic
pad
conjug
pad
nitrocellulos
membran
absorpt
pad
assembl
back
card
illustr
fig
within
nitrocellulos
membran
monoclon
antinucleoprotein
antibodi
spot
approxim
mm
proxim
end
membran
gener
test
spot
control
line
plot
horizont
line
test
spot
approxim
mm
use
biodot
dispens
system
dispens
rate
secondari
goat
antimous
igg
antibodi
dispens
membran
form
control
line
conjug
pad
prepar
desir
volum
carbon
nanotagantibodi
immunoprob
load
conjug
pad
dri
compon
assembl
mount
test
strip
insert
strip
cassett
analyt
procedur
test
system
perform
load
sampl
liquid
onto
sampl
applic
window
strip
cassett
reaction
allow
process
min
signal
test
spot
control
line
visual
record
intens
valu
test
spot
obtain
use
imag
j
softwar
http
imagejnihgovij
normal
signal
intens
sampl
obtain
subtract
signal
intens
obtain
neg
control
without
target
obtain
sampl
experi
averag
data
standard
deviat
calcul
three
individu
experi
case
neg
posit
control
sampl
run
buffer
mm
borat
buffer
ph
influenza
ainfect
allanto
fluid
use
neg
posit
control
respect
specif
evalu
molecul
includ
human
serum
albumin
bsa
lysozym
dopamin
glucos
trypton
concentr
close
relat
virus
includ
influenza
b
canin
distemp
viru
use
system
evalu
appli
volum
either
protein
viru
sampl
test
process
manner
describ
previous
evalu
perform
test
system
detect
influenza
viru
biolog
matric
allanto
fluid
inocul
influenza
viru
mdck
cell
cultur
infect
either
season
influenza
strain
season
influenza
strain
use
sampl
prior
sampl
applic
sampl
mix
sampl
run
buffer
ratio
subsequ
volum
mix
sampl
appli
onto
sampl
applic
window
strip
cassett
allow
process
describ
previous
schemat
diagram
fig
illustr
principl
system
reli
upon
specif
recognit
antigen
antibodi
molecul
carbon
nanoparticl
form
nanostr
use
report
molecul
sampl
contain
target
antigen
use
sampl
antigen
captur
carbon
nanotag
antibodi
immunoprob
load
conjug
pad
test
strip
sampl
migrat
porou
membran
capillari
action
antigencarbon
nanotag
antibodi
complex
separ
gradual
sampl
matric
mean
chromatographi
continu
move
along
test
strip
complex
reach
nitrocellulos
membran
bound
captur
antibodi
immobil
membran
form
sandwich
antibodyantigencarbon
nanotag
antibodi
complex
fig
accumul
carbon
nanotag
sandwich
immunocomplex
fiber
pore
membran
test
spot
area
result
color
chang
signal
detect
color
black
color
sem
imag
fig
excess
immunoprob
continu
move
along
test
bound
secondari
antimous
igg
antibodi
control
line
fig
show
diagram
imag
target
antigen
present
sampl
order
obtain
optim
condit
system
major
factor
contribut
directli
perform
system
systemat
investig
follow
paramet
optim
ratio
amount
particl
amount
antibodi
immunoprob
prepar
b
amount
immunoprob
load
system
c
amount
antibodi
immobil
test
area
respect
data
figur
given
esm
fig
found
follow
experiment
condit
give
best
result
carbon
nanotag
immunoprob
ratio
b
volum
immunoprob
c
concentr
antibodi
immobil
test
area
optim
condit
therefor
adopt
experi
investig
abil
optim
system
detect
influenza
viru
allanto
fluid
inocul
influenza
viru
use
sampl
optim
experiment
condit
perform
system
evalu
differ
concentr
viru
rang
tissu
cultur
infecti
dose
depict
fig
concentr
target
viru
antigen
increas
detect
signal
strength
shown
higher
suggest
detect
signal
increas
gradual
proport
number
target
influenza
viru
present
sampl
higher
signal
strength
attribut
increas
number
cluster
carbon
nanotag
label
sandwich
immunocomplex
test
spot
area
direct
signal
visual
black
spot
detect
signal
observ
visual
concentr
imag
carbon
nanotag
base
later
flow
assay
test
system
presenc
variou
influenza
viru
concentr
shown
inset
panel
semiquantit
analysi
also
perform
record
signal
intens
test
spot
area
describ
earlier
averag
normal
signal
intens
sampl
plot
concentr
target
viru
limit
detect
system
demonstr
averag
normal
signal
intens
valu
au
obtain
three
individu
experi
assess
analyt
select
system
protein
includ
evalu
sampl
molecul
human
serum
albumin
bsa
lysozym
dopamin
glucos
trypton
concentr
addit
virus
includ
influenza
b
canin
distemp
virus
also
use
sampl
order
assess
specif
system
close
relat
virus
fig
show
photo
imag
test
system
presenc
allanto
fluid
contain
influenza
viru
concentr
compar
strip
presenc
protein
virus
averag
normal
signal
intens
plot
protein
virus
also
display
n
shown
system
exhibit
distinct
black
color
test
spot
signal
high
normal
signal
intens
valu
averag
valu
au
n
presenc
allanto
fluid
contain
influenza
viru
hand
test
spot
signal
observ
protein
virus
use
sampl
result
suggest
system
demonstr
specif
test
protein
virus
determin
system
differ
system
number
studi
use
differ
techniqu
review
firstli
worth
mention
diagnosi
use
tradit
viral
cultur
method
describ
previous
tradit
cultur
method
timeconsum
techniqu
also
repres
fraction
bacteria
viru
commun
reli
cultur
condit
select
therefor
pointofcar
test
import
rapid
screen
diagnosi
influenza
viru
infect
advanc
field
nanotechnolog
led
develop
sever
nanomaterialbas
method
identif
influenza
viru
tabl
summar
overview
recent
report
techniqu
includ
system
report
studi
perform
method
includ
sensit
specif
system
also
report
exampl
zhao
et
al
describ
use
gold
nanoparticlebas
microarray
assay
detect
avian
influenza
viral
rna
limit
detect
per
assay
differ
approach
use
nanoparticl
either
concentr
sampl
enabl
signal
detect
amplifi
signal
also
report
variou
detect
level
target
influenza
protein
viru
particl
platform
exampl
includ
electrochem
sensor
integr
microfluid
system
fieldeffect
transistor
system
system
use
similar
immunoassay
principl
also
investig
whilst
zhang
et
al
report
europium
nanoparticlebas
immunoasssay
detect
influenza
viru
limit
detect
egg
infect
dose
eid
paperbas
immunoassay
use
gold
nanoparticl
enabl
detect
influenza
viru
rang
plaqueform
unit
per
assay
describ
also
note
antibodi
specif
influenza
viru
use
system
differ
system
system
antibodi
chosen
target
ligand
specif
nucleoprotein
rather
protein
hemagglutinin
neuraminidas
suscept
antigen
chang
nucleoprotein
recogn
one
abund
protein
virion
less
sensit
antigen
drift
therefor
provid
advantag
system
enabl
detect
subtyp
influenza
viru
possibl
compar
system
comparison
later
flow
immunoassay
system
although
approach
provid
similar
even
superior
detect
sensit
techniqu
complic
techniqu
requir
expens
equip
highlytrain
personnel
extens
valid
routin
use
therefor
respect
approach
later
flow
immunoassay
platform
design
rapid
pointofcar
diagnost
test
provid
signific
advantag
allow
direct
simpl
sensit
determin
influenza
viru
regard
previou
later
flow
immunoassay
system
report
detect
influenza
viru
duallay
doubletarget
gold
nanoparticl
fluoresc
dyedop
silica
nanoparticl
use
report
howev
note
strategi
use
either
differ
size
gold
nanoparticl
combin
combin
antigen
detect
method
fluoresc
base
method
complic
strategi
compar
singlelabel
direct
visual
system
exampl
system
requir
sophist
protocol
gener
optim
probe
also
need
extens
optim
procedur
prevent
nonspecif
signal
gener
special
equip
signal
interpret
order
improv
difficulti
differ
approach
use
carbon
nanoparticl
form
nanostr
report
molecul
detect
influenza
viru
therefor
explor
investig
work
carbon
nanoparticl
recogn
versatil
label
rapid
diagnost
assay
use
carbon
nanoparticl
report
later
flow
assay
system
provid
better
sensit
compar
use
either
gold
nanoparticl
latex
bead
among
differ
nanomateri
use
report
later
flow
assay
system
report
carbon
nanoparticl
cheapest
one
suspens
stabl
easi
prepar
uniqu
properti
carbon
nanomateri
good
stabil
high
contrast
inexpens
demonstr
carbon
nanotag
base
later
flow
assay
success
fabric
rapid
direct
visual
determin
influenza
viru
limit
detect
compar
exist
techniqu
system
final
point
merit
discuss
system
potenti
appli
relev
clinic
applic
order
evalu
potenti
system
import
assess
perform
system
detect
influenza
viru
relat
biolog
sampl
matrix
ie
cell
lysat
format
regard
mdck
cell
cultur
infect
either
season
influenza
strain
season
influenza
strain
use
sampl
uninfect
cell
use
neg
control
shown
influenza
infect
cell
cultur
use
sampl
distinct
black
color
test
spot
observ
high
averag
normal
signal
intens
valu
au
respect
fig
opposit
uninfect
cell
appli
system
test
spot
signal
detect
rel
low
averag
normal
signal
intens
valu
result
demonstr
system
potenti
detect
viru
biolog
matric
cross
reactiv
test
protein
demonstr
develop
rapid
detect
platform
base
later
flow
chromatograph
assay
combin
carbon
nanoparticl
form
nanostr
report
visual
detect
influenza
viru
demonstr
rapid
detect
target
viru
achiev
direct
color
visual
signal
test
area
optim
condit
system
capabl
detect
influenza
viru
influenza
ainocul
allanto
fluid
cross
reactiv
test
protein
addit
success
detect
clinic
strain
influenza
viru
cell
lysat
format
without
interfer
biolog
matric
also
demonstr
compar
tradit
cultur
method
molecular
approach
nanomaterialbas
method
carbon
nanotag
base
later
flow
assay
provid
rapid
direct
approach
detect
influenza
viru
conclus
work
demonstr
potenti
applic
detect
platform
detect
influenza
viru
complex
biolog
matric
includ
allanto
fluid
cellassoci
format
extend
futur
develop
rapid
test
clinic
applic
